Step therapy is a process your health insurance provider may require before it will cover certain drugs. Many insurance providers require step therapy for Mounjaro (a drug prescribed for type 2 ...

Please provide your email address to receive an email when new articles are posted on . Despite a mounting number of state-level laws enacted to protect vulnerable patients against step therapy ...

The frequency with which 7 of the largest Medicare Advantage plans impose step therapy protocols in their Part B drug coverage decisions varies substantially. Objectives: First, to examine 7 large ...

Step therapy occurs when your insurer requires you to use medication alternatives before another, possibly more expensive, treatment option. Depending on specific factors, you can work with your ...

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company. “I think they put the ...

Publisher’s Note: This Health Affairs Blog post is part of a supported set of posts that will be published over the next few months. Health Affairs received support for the series from the American ...

Step therapy is when Medicare Part D plans ask beneficiaries to try a more affordable drug before approving higher-cost prescriptions. In Medicare, Part D covers general prescription drugs, whereas ...

Health plan policies are increasingly relying on step therapy for cancer drugs, recent analysis from consulting firm Avalere shows. A white paper (PDF) released by the American Cancer Society Cancer ...

Over the past two decades the use of step therapy or edits by health insurers has increased significantly. Step therapy, also called step edits, implies that in a given therapeutic class lower cost ...

This article is part of a Health Affairs Forefront featured series, “Assessing The Evidence For MA Reform.” The series was developed and supported by the research firm, Stage Analytics, through a ...

The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...